A surprising mechanism that might explain how the Hippo signaling pathway promotes solid tumor growth.
Common genetic variations may help find female childhood cancer survivors at increased risk of breast cancer and who are candidates for stepped up screening.
Children with ALL gain weight during treatment, and researchers suggest that early interventions should be considered.
Read how a discovery in bacteria in the 1980s led to a promising new class of compounds for treatment of PKAN, a progressive neurodegenerative disease.
Scientists have a new strategy to enhance the anti-cancer immune response and slow tumor growth. The goal is to reprogram macrophages to eliminate tumor cells.
Presentations outline data from Genomes for Kids study, proving clinical utility of multi-platform genome sequencing for pediatric precision oncology.
Including whole-genome sequencing into clinical genomic testing found cancer-driving mutations other sequencing methods failed to identify.
The funding will support CPIC, which provides guidelines to help clinicians understand how genetic test results should be used to optimize drug therapy.
World Health Organization, St. Jude Children’s Research Hospital collaborate against childhood cancer
New global childhood cancer effort aims to cure at least 60 percent of children with six of the most common kinds of cancer worldwide by 2030.
St. Jude scientists have discovered a link between sepsis during cancer treatment and long-term neurocognitive dysfunction.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.